

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Community
Ask the community for help and clear up your study doubts
Discover the best universities in your country according to Docsity users
Free resources
Download our free guides on studying techniques, anxiety management strategies, and thesis advice from Docsity tutors
RAC Device Practice Question Set 8- US
Typology: Quizzes
1 / 2
This page cannot be seen from the preview
Don't miss anything!
Question Answer Explanation What type of meeting request is used to share information with FDA without the expectation of feedback from them? A. Pre-Sub Meeting B. Informational Meeting C. Submission Issue Request (SIR) D. Study Risk Determination Meeting B. Informational Meeting RAC Book page 101. An Informational Meeting allows sponsors to share information with the FDA, typically about device development, without expecting feedback. These meetings can help familiarize FDA reviewers with new technology or ongoing projects. In how many days should Q-Sub meeting minutes be provided to FDA after the meeting has taken place? A. 10 days B. 15 days C. 20 days D. 30 days B. 15 days What type of meeting request is used to share information with FDA without the expectation of feedback from them? A. Pre-Sub Meeting B. Informational Meeting C. Study Risk Determination D. Submission Issue Request (SIR) B. Informational Meeting In what format must Q-Subs be submitted? A. Paper Submission B. eCopy C. Email Submission D. CD-ROM B. eCopy Explanation: Under section 745(A)(b) of the FD&C Act, Q-Subs must be submitted in eCopy format. What is a Q-Sub supplement? A. A completely new request for FDA feedback. B. Any new request for feedback related to an existing Q-Sub. C. An amendment to the original Q-Sub. D. A regulatory filing unrelated to the original Q-Sub. B. Any new request for feedback related to an existing Q-Sub. Explanation: A Q-Sub supplement involves seeking feedback on the same or similar device as the original Q- Sub. What is a Q-Sub amendment? A. A new Q-Sub request. B. A request for meeting minutes. C. Additional information related to the original Q-Sub. D. A revised classification request. C. Additional information related to the original Q-Sub. What is the Pre-Sub method of feedback and timeframe? A. Written feedback only, 45 days. B. Meeting with FDA, 90 days. C. Written feedback or meeting, 70 days. D. Meeting only, 60 days. C. Written feedback or meeting, 70 days.
What is the SIR (Submission Issue Request) method of feedback and timeframe? A. Written feedback, 45 days. B. Meeting or written feedback, 21 days. C. Written feedback, 30 days. D. Meeting only, 15 days. B. Meeting or written feedback, 21 days. RAC Book page 102. Explanation: A SIR request will result in written feedback within 21 days of receipt of the meeting request. What is the Study Risk Determination method of feedback and timeframe? A. Written feedback, 30 days. B. Meeting only, 60 days. C. Written feedback only, 90 days. D. Written feedback or meeting, 30 days. A. Written feedback, 30 days. What is the Informational Meeting method of feedback and timeframe? A. Written feedback, 45 days. B. No feedback, 60 days. C. Written feedback or meeting, 90 days. D. No feedback, no specified timeframe. D. No feedback, no specified timeframe. What is the role of a Design History File (DHF) in the device development process? A. To demonstrate the financial performance of the device B. To document the design and development stages of a medical device C. To store post-market surveillance data D. To manage device recalls